What Does FDA Expect from Lykos’ Next Phase 3 MDMA Study? (Part 2) - Psychedelic Alpha
In the second of a two-part series, we look at key trial design features FDA is expected to require of any future Phase 3 study from Lykos. Here, we run through how the MDMA drug developer will be…| Psychedelic Alpha
